Comecer Group

Comecer Group Address Via Maestri del Lavoro, 90 48014 Castel Super Sector Industrial Goods & Services Bolognese Emilia - Romagna Sector Industrial Engineering Country Italy Phone +39 0546/656375 Website http://www.comecergroup.com ELITE member 12/04/2012 since ELITE Stage GET Value About ELITE Alessia Zanelli, Managing Director “Joining ELITE is an important step for us to take in order to realize our dream of being listed on Borsa Italiana Markets.” Strengths Research & development Internationalization Market Niche and quality certification Company overview Comecer SpA, an Italian company from Castel Bolognese (Province of Ravenna) founded in the mid 1970s by Carlo Zanelli, is a world leader in the field of nuclear medicine and it specialises in management, processing and dispensing systems for radiopharmaceuticals. Our mission is to design and manufacture high-technology systems in the field of nuclear medicine, isolation technology and nuclear power plant equipment, with the aim to continuously increase the accuracy and the safety of technicians, researchers, and patients. In fact, “Safety First” is the philosophy which distinguishes and identifies all Comecer policies and actions. Our vision is to contribute to progress and preserve life through the development of highly innovative technologies and sustainable solutions, according to the latest GMP (Good Manufacturing Practice) regulations. Comecer operates in the field of nuclear medicine through the production of shielding systems and equipment for special applications, both for large industrial groups and for research organisations. We also operate in the isolation technology sector, developing tailored projects for the production of isolators for the treatment of toxic substances to be used in hospitals, universities and pharmaceutical companies. Finally, we are active in the nuclear power plant equipment sector through the production of equipment for the processing, the deactivation and the disposal of radioactive substances deriving from nuclear plants. Comecer products are known and used in hospitals, universities, research centers, pharmaceutical companies and large industrial groups worldwide. Since March 2011, Fondo Italiano d’Investimento (Italian Investment Fund), a private equity vehicle founded upon an initiative of the Italian Ministry of Finance, has participated in the Comecer Group with a minority share. Starting in 2012, Comecer has acquired two companies, Veenstra and Vitrae Czech, thus becoming an integral part and founding member of the Comecer Group. Comecer Group , that employs 280 people under the leadership of President Carlo Zanelli and CEO Alessia Zanelli, has achieved a turnover of 46 million Euro in 2013. With two production sites at Castel Bolognese (Italy) and Joure (Holland), locations at Hradec Kralove (Czech Republic), Neustadt (Germany), Miami (USA), Mumbai (India) and Beijing (China), Comecer markets its products in over 100 countries worldwide through a direct sales network and thanks to prominent technological partnerships for the joint development of new products with GE Healthcare and IBA. Comecer is the only player on the Italian market exporting 90% of its products abroad, particularly to those few companies in the world which produce cyclotron and PET machines, such as General Electric, IBA and Siemens. At present, the Comecer Group is undergoing a growth phase which will allow it to further strengthen its business in the Italian market, and at the same time expand its range of products and increase its market coverage of specific geographic areas by way of a number of acquisitions. By the way, Comecer and Veenstra, undisputed leaders on a European level and amongst the most important internationally, now work together to offer excellence in every aspect of nuclear medicine: concept, electronic, mechanical, and software. ELITE - Comecer Group With this acquisition, Comecer completes its offering with the best electronic and IT technologies for nuclear medicine such as software, electronic and mechanical instruments and equipment used in nuclear medicine, radiochemistry, radiopharmacy and calibration laboratories. With the acquisition of Vitrae Czech, taking over the operating branch dealing with lead of this company belonging to the Brisk Tabor group, Comecer aims to reinforce its own production skills regarding special processes required in the production of its own equipment targeted at the nuclear medicine sector. Comecer, whilst operating in a sector characterised by high technological standards, has always implemented large investments in Research & Development in order to equip itself with the essential skills and knowledge to be at the forefront and maintain an advantage over its competitors. The company strategy is characterised by the constant enhancement of our human and technological resources, and by the optimisation of our organisational and production structure, with the aim of focusing our initiatives in the market sectors in which the Group operates and which offer the best opportunities for development. Comecer follows the product in all its phases, from its production to its use in production and nuclear medicine facilities, and certifies all its products. All systems are tested and undergo a comprehensive series of validation checks according to the applicable Italian, European and international standards and norms. In particular, a “Safety First” Code of Ethics applies inside Comecer, which is stricter than the current legislation and which places safety of the person and respect for the environment above any company policy and action. Safety is then translated into the quality of the materials and the processes, which allow Comecer to qualify its products in accordance with the highest standards in the sector. Amongst the equipment produced by the company, are the cells for the handling of radioactive substances and the automatic systems for the distribution in vials or syringes, including complete lines for the production and packaging of radiopharmaceuticals. Products / services / business lines Currently, Comecer has three business areas: Nuclear Medicine and Radiochemistry Comecer designs and manufactures systems and equipment for the safe treatment of radioactive substances used in Nuclear Medicine, ensuring minimal exposure for the operator, total decontamination and unalterability under any working conditions. In the Nuclear Medicine market, Comecer products can be found in the most advanced and prestigious research centers, universities, hospitals and pharmaceutical companies worldwide. 1MP – a new Comecer business unit: a team of experts acting as a single point of reference that assist clients in setting up a brand new radiopharmaceutical production center or a PET laboratory, or in making an existing structure compliant with GMP standards. Isolation Technology Another important sector of Comecer production is Isolation Technology. Comecer is specialized in the customized production of isolators, instruments which allow for the highest level of separation and protection during the treatment of toxic and dangerous substances (non-radioactive) for use in pharmaceutical, chemical and food-processing industries. Nuclear Power Plant Equipment Comecer, by making its experience and competency available to new market demands, has entered into the Nuclear Power Plant Equipment sector, which involves the dismantling of nuclear power plants (decommissioning). To date, Comecer is the only Italian company qualified by Sogin, a company wholly owned by the Italian Ministry of the Treasury, formed to manage the closure of Italian nuclear plants. ELITE - Comecer Group Powered by TCPDF (www.tcpdf.org).

Load more